4
Changes in Ownership
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-14-000018
Chief Scientific Officer acquired 2,000,000 shares (conversion)
- Chief Scientific Officer acquired 220,106 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
NIGALAYE ASHOK G · Chief Scientific Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-02-25 | Grant or award : show line 1 in the form | +220,106 | $0.09 | $20,008 | 12,275,289 | D |
| 2014-02-25 | Conversion : show line 2 in the form | +2,000,000 | $0.06 | $125,000 | 14,275,289 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-02-25 | Conversion : show line 3 in the form Warrants | −2,000,000 | $0.06 | $125,000 | 1,333,333 | D |
Loading xslF345X03/primary_doc.xml…